Product name | Recombinant Human IL-17A/CTLA-8 Protein |
---|---|
Catalog No. | RP00212 |
Description | Recombinant Human IL-17A/CTLA-8 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ile20-Ala155) of human IL-17A (Accession #NP_002181.1) fused with a 6×His tag at the C-terminus. |
Bio-Activity | 1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant human IL17RA at 2 μg/mL (100 μL/well) can bind Recombinant human IL-17A, the EC50 of human IL-17A is 32.5-130 ng/mL. 2.Measured by its ability to induce IL-6 secretion by Hela cells. The ED50 for this effect is 2.64-10.58 ng/mL, corresponding to a specific activity of 9.45×104~3.79×105 units/mg. |
Purity | > 95% by SDS-PAGE. |
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
Species | Human |
Calculated MW | 16.37 kDa |
Synonym | IL17A; CTLA-8; CTLA8; IL-17; IL-17A; IL17; interleukin-17A; CTLA-8; CTLA8; IL-17; IL-17A; IL17 |
---|---|
Expression Host | HEK293 cells |
Tag | C-His |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.